Vebectotamab Vedotin Combined With Pucotelimab in the Treatment of Locally Advanced Laryngeal Carcinoma
Tang-Du Hospital
Tang-Du Hospital
Eli Lilly and Company
University of Cincinnati
University of Arizona
National Institutes of Health Clinical Center (CC)
University of Colorado, Denver
Turning Point Therapeutics, Inc.
University of Chicago
Ensem Therapeutics
PMV Pharmaceuticals, Inc
Tubulis GmbH
Eli Lilly and Company
UNC Lineberger Comprehensive Cancer Center
Merus B.V.
M.D. Anderson Cancer Center
Betta Pharmaceuticals Co., Ltd.
Theravectys S.A.
Kidney Cancer Research Bureau
Perspective Therapeutics
Second Life Therapeutics
Onchilles Pharma Inc
Eli Lilly and Company
Kura Oncology, Inc.
Inhibrx Biosciences, Inc
VM Oncology, LLC
Takeda
BicycleTx Limited
Shasqi, Inc.
ITM Oncologics GmbH
University of Arkansas
Maastricht University Medical Center
LigaChem Biosciences, Inc.
University of Kansas Medical Center
Coordination Pharmaceuticals, Inc.
Hookipa Biotech GmbH
Bolt Biotherapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Providence Health & Services
National Institutes of Health Clinical Center (CC)
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
Hoffmann-La Roche
West China Hospital
M.D. Anderson Cancer Center
Rapa Therapeutics LLC